Safety and Tolerability Study of MDV3100 in Combination With Docetaxel in Men With Advanced Prostate Cancer
Clinical trial NCT01565928 · COMPLETED
Trial details
- NCT number
- NCT01565928
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-01-24
- Primary completion
- 2013-07-01
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.